Trustar Capital acquires Chinese throat medicine maker Guilong Pharmaceutical
Trustar Capital, the private equity (PE) arm of Chinese alternative investment firm CITIC Capital Holdings, has wrapped up its acquisition ...
Read moreDetailsTrustar Capital, the private equity (PE) arm of Chinese alternative investment firm CITIC Capital Holdings, has wrapped up its acquisition ...
Read moreDetailsCarlyle Group Inc and Trustar Capital are planning to raise $4 billion from wealth funds to buy part of their ...
Read moreDetails© 2023 earth-news.info
© 2023 earth-news.info